AMP-activated protein kinase: an emerging drug target to regulate imbalances in lipid and carbohydrate metabolism to treat cardio-metabolic diseases: Thematic Review Series: New Lipid and Lipoprotein Targets for the Treatment of Cardiometabolic Diseases

The adenosine monophosphate-activated protein kinase (AMPK) is a metabolic sensor of energy metabolism at the cellular as well as whole-body level. It is activated by low energy status that triggers a switch from ATP-consuming anabolic pathways to ATP-producing catabolic pathways. AMPK is involved i...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Srivastava, Rai Ajit K., Pinkosky, Stephen L., Filippov, Sergey, Hanselman, Jeffrey C., Cramer, Clay T., Newton, Roger S.
Formato: Artigo
Idioma:Inglês
Publicado em: The American Society for Biochemistry and Molecular Biology 2012
Assuntos:
Thematic Review Section: New Lipid and Lipoprotein Targets for the Treatment of Cardiometabolic Diseases
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3494254/
https://ncbi.nlm.nih.gov/pubmed/22798688
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1194/jlr.R025882
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados